EXHIBIT 32




      In connection with the quarterly report of EFT BioTech Holdings, Inc.,
(the "Company") on Form 10-Q for the quarter ended June 30, 2010 as filed with
the Securities and Exchange Commission (the "Report") Jack Jie Qin, the
Principal Executive and Principal Financial Officer of the Company, certify
pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:



(1)  The Report fully complies with the  requirements  of Section 13(a) or 15(d)
     of the Securities Exchange Act of 1934; and

(2)  The information  contained in the Report fairly  presents,  in all material
     respects, the financial condition and results of operation of the company.


 August 9, 2010                           /s/s Jack Jie Qin
                                          ------------------------------
                                          Jack Jie Qin, Principal Executive and
                                            Financial Officer